Thus, the concept of atherogenic dyslipidemia – applied to subjects with hypo HDL-C, hypertriglyceridemia and normal LDL-C, but increases in some ALT components – has been associated with an elevated risk of CVD events (10–12). The gene discussed is GPT; the disease is metabolic syndrome.